Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
100%
CSF Biomarkers
100%
Clinical Utility
100%
Parkinson Patients
45%
C-Abl
36%
Parkin
36%
Alpha-synuclein (α-syn)
36%
Dysregulation
18%
Disease Severity
18%
Multiple Reaction Monitoring-mass Spectrometry (MRM-MS)
18%
Phosphorylation
18%
Parkinson's Disease Monitoring
9%
Novel Diagnostics
9%
Disease Pathogenesis
9%
Signaling Cascades
9%
Neuronal Cell Death
9%
Diagnostic Marker
9%
Specificity Protein 1
9%
Patient Care
9%
Clinical Research Projects
9%
Severe Stage
9%
Clinical Cohort
9%
Definitive Diagnosis
9%
Patients with Parkinson's Disease
9%
Receptor Tyrosine Kinase
9%
Tyrosine Kinase c-Abl
9%
Intrinsically Linked
9%
Patient Advocacy Groups
9%
Protein Biomarkers
9%
Relative Concentration
9%
Disease Marker
9%
Parkinson's Disease Biomarkers
9%
Diagnostic/prognostic Biomarkers
9%
Tryptic Peptides
9%
Two-path
9%
Phosphorylation State
9%
Patient Monitoring
9%
Accurate Diagnosis
9%
Quantitative Assay
9%
Clinical Manifestations
9%
Disease-specific
9%
NINDS
9%
Biochemistry, Genetics and Molecular Biology
Synuclein
100%
Mass Spectrometry
50%
phosphorylation
50%
Clinical Research
25%
Cell Death
25%
Non-Receptor Tyrosine Kinase
25%
Protein Phosphorylation
25%
Fox
25%
Protein Kinase C
25%
Prognostic Biomarker
25%
Peptide
25%